Skip to main content
Log in

Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

This prospective, stratified, randomized, single-blind, placebo-controlled multicentre study investigated the safety and effectiveness of reducing blood loss and preventing venous thromboembolism (VTE) during posterior lumbar interbody fusion (PLIF) in patients with stenosis or spondylolisthesis using the combination of tranexamic acid (TXA) and rivaroxaban.

Methods

The Autar score was evaluated in patients after admission. Patients with an Autar score ≤ 10 were randomized to group A or B. Group A was the placebo-controlled group. Patients in group B were treated with 1 g TXA via intravenous injection and 1 g TXA for external use. Patients with an Autar score > 10 were randomized to group C or D. Patients in group C were treated with 10-mg rivaroxaban qd for 35 days after surgery. Patients in group D received the same treatment as those in group B intra-operatively and as those in group C post-operatively.

Results

A total of 599 patients from eight hospitals participated in this clinical trial. The total blood loss, intra-operative blood loss, and drainage volume were reduced by the administration of TXA (group A vs group B, P < 0.01; group C vs group D, P < 0.01), and the blood transfusion rate was also decreased (group A vs group B, P < 0.01; group C vs group D, P < 0.01). There were no significant differences (P > 0.05) in the VTE incidence rates among group A and group B. In patients with high-risk thrombosis, the number of patients with VTE was only three and seven after the application of rivaroxaban. Epidural haematoma was not discovered in any patients in our trial.

Conclusion

The combined application of tranexamic acid and rivaroxaban significantly reduced the amount of blood loss and the transfusion rate during PLIF surgery and avoided an increase in the probability of thrombosis and the occurrence of epidural haematoma.

Trial registration number and date of registration

ChiCTR-1800016430

2018-06-01

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

We declared that materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes, without breaching participant confidentiality. The datasets generated during the current study are available in the Figshare repository https://figshare.com/s/b4128bd83127f2056e96.

References

  1. Hu SS (2004) Blood loss in adult spinal surgery. Eur Spine J 13(Suppl 1):S3–S5

    Article  Google Scholar 

  2. Szpalski M, Gunzburg R, Sztern B (2004) An overview of blood-sparing techniques used in spine surgery during the perioperative period. Eur Spine J 13(Suppl 1):S18–S27

    Article  Google Scholar 

  3. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 102(4):727–732

    Article  CAS  Google Scholar 

  4. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81(1):2–10

    Article  CAS  Google Scholar 

  5. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg (Br) 83(5):702–705

    Article  CAS  Google Scholar 

  6. Perel P, Clayton T, Altman DG et al (2014) Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study. PLoS Med 11(6):e1001664

    Article  Google Scholar 

  7. Yang B, Li H, Wang D, He X, Zhang C, Yang P (2013) Systematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery. PLoS One 8(2):e55436

    Article  CAS  Google Scholar 

  8. Wang Q, Liu J, Fan R et al (2013) Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. Eur Spine J 22(9):2035–2038

    Article  Google Scholar 

  9. Peters A, Verma K, Slobodyanyuk K et al (2015) Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Spine (Phila Pa 1976) 40(8):E443–E449

    Article  Google Scholar 

  10. Raksakietisak M, Sathitkarnmanee B, Srisaen P et al (2015) Two doses of tranexamic acid reduce blood transfusion in complex spine surgery: a prospective randomized study. Spine (Phila Pa 1976) 40(24):E1257–E1263

    Article  Google Scholar 

  11. Shi H, Ou Y, Jiang D, Quan Z, Zhao Z, Zhu Y (2017) Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: a randomized trial. Medicine (Baltimore) 96(1):e5718

    Article  CAS  Google Scholar 

  12. Kvederas G, Porvaneckas N, Andrijauskas A et al (2013) A randomized double-blind clinical trial of tourniquet application strategies for total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(12):2790–2799

    Article  Google Scholar 

  13. Xie J, Lenke LG, Li T et al (2015) Preliminary investigation of high-dose tranexamic acid for controlling intraoperative blood loss in patients undergoing spine correction surgery. Spine J 15(4):647–654

    Article  Google Scholar 

  14. Liang J, Liu H, Huang X et al (2016) Using tranexamic acid soaked absorbable gelatin sponge following complex posterior lumbar spine surgery: a randomized control trial. Clin Neurol Neurosurg 147:110–114

    Article  Google Scholar 

  15. Kim KT, Kim CK, Kim YC et al (2017) The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. Eur Spine J 26(11):2851–2857

    Article  Google Scholar 

  16. Cheriyan T, Maier SP 2nd, Bianco K et al (2015) Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J 15(4):752–761

    Article  Google Scholar 

  17. Tsutsumimoto T, Shimogata M, Ohta H, Yui M, Yoda I, Misawa H (2011) Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study. Spine (Phila Pa 1976) 36(23):1913–1918

    Article  Google Scholar 

  18. Griffiths NJ (1979) Factors affecting the fibrinolytic response to surgery. Ann R Coll Surg Engl 61(1):12–16

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339(4):245–253

    Article  CAS  Google Scholar 

  20. Mannucci PM, Levi M (2007) Prevention and treatment of major blood loss. N Engl J Med 356(22):2301–2311

    Article  CAS  Google Scholar 

  21. Henry DA, Carless PA, Moxey AJ et al (2007) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4:CD001886

    Google Scholar 

  22. Gill JB, Chin Y, Levin A, Feng D (2008) The use of antifibrinolytic agents in spine surgery. A meta-analysis. J Bone Joint Surg Am 90(11):2399–2407

    Article  Google Scholar 

  23. Nishihara S, Hamada M (2015) Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis. Bone Joint J 97-B(4):458–462

    Article  CAS  Google Scholar 

  24. Levy JH, Moore KT, Neal MD et al (2018) Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers. J Thromb Haemost 16(1):54–64

    Article  CAS  Google Scholar 

  25. Du W, Zhao C, Wang J, Liu J, Shen B, Zheng Y (2015) Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery. J Orthop Surg Res 10:78

    Article  Google Scholar 

  26. Shaieb MD, Watson BN, Atkinson RE (1999) Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplast 14(4):432–438

    Article  CAS  Google Scholar 

  27. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126(3 Suppl):287S–310S

    Article  CAS  Google Scholar 

  28. Ricket AL, Stewart DW, Wood RC et al (2016) Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban or enoxaparin. Ann Pharmacother 50(4):270–275

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yunzhen Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no potential conflict of interest.

Ethics approval

This retrospective, stratified, randomized, single-blind, placebo-controlled multicentre study was approved by the Medical Ethics Committee of Qilu Hospital of Shandong University (no. 2018059) and was registered in the Chinese Clinical Trial Registry (ChiCTR-1800016430).

Consent to participate

All subjects were aware of the clinical trial and agreed to participate.

Consent for publication

All authors have approved the manuscript and agree with submission to International Orthopaedics.

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Li, Y., Liu, D. et al. Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial. International Orthopaedics (SICOT) 44, 2079–2087 (2020). https://doi.org/10.1007/s00264-020-04699-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-020-04699-3

Keywords

Navigation